These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4104378)

  • 21. [Different aspects of using antirhesus immunoglobulin].
    Belozerova VI
    Probl Gematol Pereliv Krovi; 1979 Oct; 24(10):49-54. PubMed ID: 92019
    [No Abstract]   [Full Text] [Related]  

  • 22. Instrumented PVP-augmented antiglobulin tests. 3. IgG-coated cells in ABO incompatible babies; depressed hemoglobin levels in type A babies of type O mothers.
    Hsu TC; Rosenfield RE; Rubinstein P
    Vox Sang; 1974; 26(4):326-33. PubMed ID: 4842155
    [No Abstract]   [Full Text] [Related]  

  • 23. Fetal-maternal incompatibility.
    O'Riordan JP
    Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117428
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ABO incompatible pregnancies and the origin of isoantibodies in mothers of infants with ABO hemolytic disease of the newborn.
    Grundbacher FJ
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Jul; 136(1):68-78. PubMed ID: 4234969
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of Rh immunization in Finland. A national study, 1969--1977.
    Eklund J
    Acta Paediatr Scand Suppl; 1978; (274):1-57. PubMed ID: 82366
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rh and ABO incompatibility].
    Brandl K
    Wien Klin Wochenschr; 1965 Oct; 77(42):814-5. PubMed ID: 4956671
    [No Abstract]   [Full Text] [Related]  

  • 27. [Separation of blood group agglutinins on DEAE-cellulose for the determination of O/A incompatibility].
    Hernandez R; Just M; Steurenthaler W
    Experientia; 1975 Jan; 31(1):129-30. PubMed ID: 234387
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of maternal Rh sensitization: anti-Rh immune globulin.
    Wilson WB
    J Miss State Med Assoc; 1970 Feb; 11(2):53-6. PubMed ID: 4189158
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunoglobulin content of the amniotic fluid and umbilical cord blood].
    Donat H
    Zentralbl Gynakol; 1979; 101(6):394-403. PubMed ID: 110004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

  • 31. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention and anticipation of Rhesus isoimmunization].
    Ravina JH; Poulain M; Lepage F
    Presse Med (1893); 1969 Oct; 77(43):1511-3. PubMed ID: 4187490
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunoglobulins in the 1st years of life].
    Vivell O
    Arch Kinderheilkd; 1970; 181(3):211-7. PubMed ID: 4098998
    [No Abstract]   [Full Text] [Related]  

  • 34. Problem of blood factor C of A-B-O system.
    Socha WW; Wiener AS
    N Y State J Med; 1973 Sep; 73(17):2144-56. PubMed ID: 4125674
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental and clinical studies on 1st transabdominal flooding of the maternal circulation with fetal erythrocytes (new aspects of Rh sensitization)].
    Hindemann P
    Geburtshilfe Frauenheilkd; 1966 Oct; 26(10):1359-72. PubMed ID: 4162573
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between placental alkaline phosphatase and ABO system polymorphisms. Effects on the clinical manifestations of feto-maternal ABO incompatibility.
    Bottini E; Lucarelli P; Orzalesi M; Palmarino R; Di Mino M; Gloria F; Terrenato L; Spennati GF
    Vox Sang; 1972; 23(5):413-9. PubMed ID: 4627823
    [No Abstract]   [Full Text] [Related]  

  • 40. Chromatographic separation and serologic analysis of antibodies in the sera of mothers with ABO incompatibility.
    Kuśnierz G
    Arch Immunol Ther Exp (Warsz); 1974; 22(2):161-5. PubMed ID: 4209990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.